Dimed S.A. Distribuidora de Medicamentos (BVMF:PNVL3)
Brazil flag Brazil · Delayed Price · Currency is BRL
13.23
-0.04 (-0.30%)
At close: Jan 30, 2026

BVMF:PNVL3 Income Statement

Millions BRL. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
5,2934,9424,4613,9903,2252,819
Revenue Growth (YoY)
9.87%10.79%11.79%23.72%14.41%3.47%
Cost of Revenue
3,5763,3643,0792,7452,2311,988
Gross Profit
1,7181,5781,3821,245994.64831.01
Selling, General & Admin
1,4671,3681,2101,099907.41726.33
Other Operating Expenses
13.1112.919.538-15.5611.29
Operating Expenses
1,4801,3811,2201,107891.85737.62
Operating Income
237.17197.33161.89137.84102.7893.39
Interest Expense
-122.05-103.97-102.57-70.03-37.12-35.31
Interest & Investment Income
33.9230.9934.3918.1816.636.05
Other Non Operating Income (Expenses)
-13.18-9.73-6.81-7.012.2-9.6
EBT Excluding Unusual Items
135.86114.6286.978.9984.4954.54
Gain (Loss) on Sale of Assets
-2.39-4.03-2.26-2.07-2.74-1.85
Other Unusual Items
1.731.976.951.511.490.62
Pretax Income
135.21112.5691.5878.4383.2453.3
Income Tax Expense
22.387.06-1.32-7.923.81-2.85
Net Income
112.83105.5192.9186.3579.4356.15
Net Income to Common
112.83105.5192.9186.3579.4356.15
Net Income Growth
8.96%13.57%7.60%8.71%41.45%-26.84%
Shares Outstanding (Basic)
149149149149150151
Shares Outstanding (Diluted)
149150150149150152
Shares Change (YoY)
-0.07%0.42%0.38%-0.30%-1.27%11.84%
EPS (Basic)
0.760.710.620.580.530.37
EPS (Diluted)
0.750.700.620.580.530.37
EPS Growth
8.86%12.90%6.90%9.24%43.27%-34.59%
Free Cash Flow
285.88101.73182.256.1821.1367.1
Free Cash Flow Per Share
1.920.681.220.380.140.44
Dividend Per Share
--0.252-0.1750.136
Dividend Growth
----28.37%-19.11%
Gross Margin
32.45%31.94%30.97%31.20%30.84%29.48%
Operating Margin
4.48%3.99%3.63%3.45%3.19%3.31%
Profit Margin
2.13%2.14%2.08%2.16%2.46%1.99%
Free Cash Flow Margin
5.40%2.06%4.08%1.41%0.66%2.38%
EBITDA
300.92367.87362.04322.41260.56211.17
EBITDA Margin
5.68%7.44%8.12%8.08%8.08%7.49%
D&A For EBITDA
63.75170.54200.15184.57157.77117.78
EBIT
237.17197.33161.89137.84102.7893.39
EBIT Margin
4.48%3.99%3.63%3.45%3.19%3.31%
Effective Tax Rate
16.55%6.27%--4.58%-
Revenue as Reported
5,2934,9424,4613,9903,225-
Advertising Expenses
-33.1629.3426.2119.8817.54
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.